Oculis Holding AG (OCS) Short-term Investments (2023 - 2026)

Oculis Holding AG's (OCS) quarterly Short-term Investments came in at $201.1 million in Q1 2026, up 48.13% year-on-year from $135.8 million in Q1 2025, and up 22.05% quarter-over-quarter from $164.8 million in Q4 2025.

Oculis Holding AG (OCS) Short-term Investments (2023 - 2026) Analysis & Trends

Oculis Holding AG's Short-term Investments history runs 4 years deep, the most recent figure standing at $201.1 million for Q1 2026.

  • On a quarterly basis, Short-term Investments rose 48.13% year-over-year to $201.1 million in Q1 2026; TTM through Mar 2026 was $201.1 million, a 48.13% increase from a year earlier, with the FY2025 full-year figure at $158.8 million, up 96.92% from the prior year.
  • Short-term Investments grew to $201.1 million in Q1 2026 per OCS's latest filing, from $164.8 million in the prior quarter.
  • Across five years, Short-term Investments topped out at $201.1 million in Q1 2026 and bottomed at -$85.9 million in Q3 2023.
  • The 4-year median for Short-term Investments is $81.5 million (2024), against an average of $68.4 million.
  • Across the five-year window, Short-term Investments surged 232.65% in 2024 and surged 41.63% in 2025, its largest moves.
  • Year by year, Short-term Investments stood at -$61.1 million in 2023, then jumped by 232.65% to $81.0 million in 2024, then jumped by 103.41% to $164.8 million in 2025, then rose by 22.05% to $201.1 million in 2026.
  • Per Business Quant, the three latest OCS Short-term Investments figures stand at $201.1 million (Q1 2026), $164.8 million (Q4 2025), and $123.4 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Alnylam Pharmaceuticals 35.71 Bn 32.70 Bn 959.66 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 201.09 Mn
Dec 31, 2025 164.76 Mn
Sep 30, 2025 123.44 Mn
Jun 30, 2025 116.00 Mn
Mar 31, 2025 135.76 Mn
Dec 31, 2024 81.00 Mn
Sep 30, 2024 80.61 Mn
Jun 30, 2024 81.91 Mn
Mar 31, 2024 63.67 Mn
Dec 31, 2023 -61.06 Mn
Sep 30, 2023 -85.90 Mn
Jun 30, 2023 -80.16 Mn